Abstract
Gram-positive cocci are responsible for many severe infections in community and hospital settings, and these multidrug resistant organisms have increased markedly in the past decade. This trend is particularly evident for methicillin/ oxacillin-resistant Staphylococcus aureus (MRSA). MRSA is any strain of Staphylococcus aureus that has developed resistance to beta-lactam antibiotics, which include the penicillins (methicillin, dicloxacillin, nafcillin, oxacillin, etc.) and the cephalosporins. S. aureus strains have developed resistance to almost all antibiotics, thereby complicating disease management. Antibiotics are an essential part of modern medicine and that has helped dramatically in curing patients suffering from bacterial infections. However, emerging antimicrobial resistance in bacteria threatens to undermine the management of bacterial infections. A number of factors, which may promote antimicrobial resistance such as availability of antimicrobials without prescription, suboptimal hygiene, immunosuppression due to malnutrition or HIV, aggressive cancer chemotherapy and an increase in organ transplantation have resulted in hospitalized patients with immune compromise at high risk of nosocomial infections. The emergence of antibiotic-resistant mutants among bacteria is seemingly inevitable, that results in the decreased efficacy and withdrawal of the antibiotic from wide-spread usage. The purpose of this review is to discuss the increase in isolates of multidrug resistant S. aureus which has created an urgent need for the development of new anti-staphylococcal agents.
Keywords: Staphylococcus aureus, MRSA, antibiotics, mechanism of resistance
Anti-Infective Agents
Title:Emergence of Methicillin-Resistant Staphylococcus aureus (MRSA) as a Public-Health Threat and Future Directions of Antibiotic Therapy for MRSA Infections
Volume: 10 Issue: 2
Author(s): Harsha Patel, Yogeshkumar Vaghasiya, BRM Vyas and Sumitra Chanda
Affiliation:
Keywords: Staphylococcus aureus, MRSA, antibiotics, mechanism of resistance
Abstract: Gram-positive cocci are responsible for many severe infections in community and hospital settings, and these multidrug resistant organisms have increased markedly in the past decade. This trend is particularly evident for methicillin/ oxacillin-resistant Staphylococcus aureus (MRSA). MRSA is any strain of Staphylococcus aureus that has developed resistance to beta-lactam antibiotics, which include the penicillins (methicillin, dicloxacillin, nafcillin, oxacillin, etc.) and the cephalosporins. S. aureus strains have developed resistance to almost all antibiotics, thereby complicating disease management. Antibiotics are an essential part of modern medicine and that has helped dramatically in curing patients suffering from bacterial infections. However, emerging antimicrobial resistance in bacteria threatens to undermine the management of bacterial infections. A number of factors, which may promote antimicrobial resistance such as availability of antimicrobials without prescription, suboptimal hygiene, immunosuppression due to malnutrition or HIV, aggressive cancer chemotherapy and an increase in organ transplantation have resulted in hospitalized patients with immune compromise at high risk of nosocomial infections. The emergence of antibiotic-resistant mutants among bacteria is seemingly inevitable, that results in the decreased efficacy and withdrawal of the antibiotic from wide-spread usage. The purpose of this review is to discuss the increase in isolates of multidrug resistant S. aureus which has created an urgent need for the development of new anti-staphylococcal agents.
Export Options
About this article
Cite this article as:
Patel Harsha, Vaghasiya Yogeshkumar, Vyas BRM and Chanda Sumitra, Emergence of Methicillin-Resistant Staphylococcus aureus (MRSA) as a Public-Health Threat and Future Directions of Antibiotic Therapy for MRSA Infections, Anti-Infective Agents 2012; 10 (2) . https://dx.doi.org/10.2174/2211362611208020149
DOI https://dx.doi.org/10.2174/2211362611208020149 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
Call for Papers in Thematic Issues
An Overview of Drugs for Multiple Targets and Variants of SARS-CoV-2 Through Artificial Intelligence, Machine Learning, Deep Learning, and Experimental Analysis
The emergence and rapid evolution of SARS-CoV-2 variants have posed significant challenges in the ongoing fight against the COVID-19 pandemic. The development of effective treatments for multiple viral targets and variants demands innovative approaches, including artificial intelligence (AI), machine learning (ML), and deep learning (DL) techniques. This special issue aims ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
An Update to Enterococcal Bacteremia: Epidemiology, Resistance, and
Outcome
Infectious Disorders - Drug Targets Importance of Oral Health in Pregnancy: A Mini-symposium
Current Women`s Health Reviews Bergenin - A Biologically Active Scaffold: Nanotechnological Perspectives
Current Topics in Medicinal Chemistry Coarctation of the Aorta - The Current State of Surgical and Transcatheter Therapies
Current Cardiology Reviews Effect of Silver Nanoparticles (AgNPs) on <i>Candida albicans, Candida dubliniensis</i> and <i>Candida guilliermondii</i>
Current Drug Therapy Plant-Derived Products as Antibacterial and Antifungal Agents in Human Health Care
Current Medicinal Chemistry Linezolid Activity Against Disseminated Listeria monocytogenes Meningitis and Central Nervous System Abscesses: Focus on Early Drug Myelotoxicity
Current Drug Safety Single Photon Emission Tomography in the Diagnostic Assessment of Cardiac and Vascular Infectious Diseases
Current Radiopharmaceuticals Bedside Lung Ultrasound in the Care of the Critically Ill
Current Respiratory Medicine Reviews Prevention of Ischemic Stroke: Antithrombotic Therapy in Cardiac Embolism
Current Drug Targets Anti-MRSA Cephems: An Update
Current Medicinal Chemistry - Anti-Infective Agents Arterial Duct Stenting in Congenital Heart Disease with Duct-Dependent Pulmonary Circulation
Current Pediatric Reviews Can Infectious Biofilm be Controlled by Blocking Bacterial Communication?
Medicinal Chemistry Genome Variability in Gram-Positive Pathogenic Bacteria - Impact on Virulence and Evolution
Current Genomics The FDG-PET Revolution of Medical Imaging – Four Decades and Beyond
Current Molecular Imaging (Discontinued) Current Developments in Therapeutic and Diagnostic Strategies for Q Fever: Glimpses of Patent Analysis
Recent Patents on Anti-Infective Drug Discovery Antibacterial Function of the Human Cathelicidin-18 Peptide (LL-37) between Theory and Practice
Protein & Peptide Letters Unusual Clinical Manifestations of the Antiphospholipid Syndrome
Current Rheumatology Reviews The Role of 18FDG PET/CT in the Assessment of Endocarditis, Myocarditis and Pericarditis
Current Radiopharmaceuticals Invasive Aspergillosis in Children and Adolescents
Current Pharmaceutical Design